Tech Company Financing Transactions
Recombine Funding Round
Recombine secured a $8.4 million funding round on 7/8/2016. Backers included private investors.
Transaction Overview
Company Name
Announced On
7/8/2016
Transaction Type
Venture Equity
Amount
$8,438,335
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 3 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1140 Bdwy. 1100
New York, NY 10001
USA
New York, NY 10001
USA
Phone
Website
Email Address
Not Recorded
Overview
Recombine provides comprehensive and cost-effective clinical genetic testing. Recombine's genetic test is designed to deliver clear and actionable genetic information and is based on input from leading healthcare providers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alexander Bisignano
Chief Scientific Officer
Santiago Munne
Browse more venture capital transactions:
Prev: 7/8/2016: Lantos Technologies venture capital transaction
Next: 7/8/2016: Admiral venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC transactions reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs